ESG

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

FPX Nickel's massive Baptiste project could supply low-carbon nickel for EVs, but it first needs to win over the public and regulators. Here's what's at stake.

A new framework from LatticeFlow AI and Unique AI translates Swiss financial regulations into auditable code, paving the way for safer AI in banking.

Israeli startup Protai is set to reveal promising preclinical data for its cancer drug, PRT-001, powered by its unique proteomics-aware AI platform.

Celebrating 30 years, Topband's journey from a local supplier to a global intelligent solutions giant mirrors China's industrial evolution.

A new partnership between South Korea's GCCL and Europe's Medicover MICS promises to streamline drug development by creating a seamless East-West axis.

OPEX Corporation launches the Velo Series, powered by InoTec, challenging market leaders with scanners designed for every scale of digital transformation.

Two tech giants unite to extend AI beyond the data center, promising a faster, greener, and more accessible future for artificial intelligence.

As XRP's path to $10 remains a long-term goal, investors are eyeing early-stage projects like Pepeto, a 'meme-utility' that has raised over $7M.

A new partnership allows FranklinWH battery owners to join Origin's VPP, unlocking new earnings while setting a new industry standard for warranty protection.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

The BDC generated a robust 12.52% yield, but a $7.2M unrealized loss in equities pulled down its net asset value, painting a complex picture.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

A California charter network's impressive academic gains are forcing a rethink on the effectiveness of non-classroom-based learning for diverse students.

A landmark study of 2.8 million people unpacks the complex causes of food allergies, vindicates vaccines, and offers parents clarity on what they can control.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

Miller Electric's new battery-powered TIG welder promises all-day uptime and precision welds anywhere, challenging competitors in a rapidly growing market.

AB Science's Masivet gets key FDA designation, paving the way for a new targeted cancer therapy for dogs and a major strategic win for the company.

Natixis CIB and NineDot Energy secure massive financing for 28 battery sites, aiming to stabilize NYC's grid and accelerate its clean energy transition.